These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 17983378)

  • 41. Adverse cutaneous drug eruptions and HIV: a clinician's global perspective.
    Todd G
    Dermatol Clin; 2006 Oct; 24(4):459-72, vi. PubMed ID: 17010776
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial damage in all types of T-lymphocyte-mediated drug-induced eruptions.
    Verneuil L; Leboeuf C; Vidal JS; Ratajczak P; Comoz F; Ameisen JC; Janin A
    Arch Dermatol; 2011 May; 147(5):579-84. PubMed ID: 21576578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome.
    Wei CY; Chung WH; Huang HW; Chen YT; Hung SI
    J Allergy Clin Immunol; 2012 Jun; 129(6):1562-9.e5. PubMed ID: 22322005
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelial cell apoptosis in severe drug-induced bullous eruptions.
    Verneuil L; Ratajczak P; Allabert C; Leboeuf C; Comoz F; Janin A; Ameisen JC
    Br J Dermatol; 2009 Dec; 161(6):1371-5. PubMed ID: 19575754
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe delayed skin reactions related to drugs in the paediatric age group: A review of the subject by way of three cases (Stevens-Johnson syndrome, toxic epidermal necrolysis and DRESS).
    Belver MT; Michavila A; Bobolea I; Feito M; Bellón T; Quirce S
    Allergol Immunopathol (Madr); 2016; 44(1):83-95. PubMed ID: 26089185
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome.
    Ishida T; Kano Y; Mizukawa Y; Shiohara T
    Allergy; 2014 Jun; 69(6):798-805. PubMed ID: 24749495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity.
    Nyfeler B; Pichler WJ
    Clin Exp Allergy; 1997 Feb; 27(2):175-81. PubMed ID: 9061217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic drug reactions with skin involvement: Stevens-Johnson syndrome, toxic epidermal necrolysis, and DRESS.
    Darlenski R; Kazandjieva J; Tsankov N
    Clin Dermatol; 2015; 33(5):538-41. PubMed ID: 26321400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
    Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
    J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J; Roujeau JC; Binaghi M; Soubrane G; Muraine M
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Drug allergy].
    Sueki H
    Nihon Rinsho; 2009 Nov; 67(11):2139-43. PubMed ID: 19899530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
    Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M;
    Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests.
    Kanny G; Pichler W; Morisset M; Franck P; Marie B; Kohler C; Renaudin JM; Beaudouin E; Laudy JS; Moneret-Vautrin DA
    J Allergy Clin Immunol; 2005 Jan; 115(1):179-85. PubMed ID: 15637566
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
    Ghislain PD; Roujeau JC
    Dermatol Online J; 2002 Jun; 8(1):5. PubMed ID: 12165215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome.
    Takahashi R; Kano Y; Yamazaki Y; Kimishima M; Mizukawa Y; Shiohara T
    J Immunol; 2009 Jun; 182(12):8071-9. PubMed ID: 19494333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Lymphoblast transformation colorimetry in the diagnosis of drug hypersensitivity].
    Szabó I; Gonda A; Bakos B; Tóth K; Hunyadi J
    Orv Hetil; 1998 Oct; 139(40):2379-82. PubMed ID: 9796355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
    Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
    Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Borchers AT; Lee JL; Naguwa SM; Cheema GS; Gershwin ME
    Autoimmun Rev; 2008 Sep; 7(8):598-605. PubMed ID: 18603022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.